A Rare Case of Chorea-Acanthocytosis in India: Clinical Presentation, Diagnosis, and Management

Chorea-acanthocytosis (ChAc) is a rare autosomal recessive neurodegenerative disorder classified under Neuroacanthocytosis syndromes. It is characterized by progressive neurological decline, psychiatric symptoms, and the presence of irregularly shaped red blood cells (acanthocytes) on peripheral blood smears. ChAc remains underdiagnosed due to its rarity and variable presentation. This case report describes a 44-year-old male from India, born of a consanguineous marriage, who presented with self-mutilating lip-biting or lingual dystonia, generalized chorea, and a history of seizures. The patient exhibited psychiatric symptoms including depression and agitation in addition to neurological features such as hypophonic speech, slowed saccades, and hypotonia. Initial diagnoses of tardive dyskinesia and generalized tonic-clonic seizures were revised following referral to neurology. Peripheral blood smears revealed acanthocytosis, and whole-exome sequencing confirmed a homozygous mutation in the VPS13A gene, leading to the diagnosis of ChAc. MRI findings included bilateral caudate and lentiform nucleus atrophy, with mild cerebral atrophy. The patient was treated symptoms were managed with antiepileptics, dopamine receptor antagonists, anticholinergics and vitamin supplementation, and vitamin supplementation, resulting in significant improvement in mandibular and lingual symptoms. Dental guards were provided to prevent further oral injury. This case highlights the importance of considering ChAc in patients presenting with neuropsychiatric and movement disorder symptoms, especially in the context of consanguinity. Early recognition and multidisciplinary management are crucial to improving quality of life. By documenting this rare case, we aim to enhance clinical awareness and facilitate early diagnosis of ChAc in resource-limited settings KEYWORDS chorea-acanthocytosis (Chac), neuroacanthocytosis syndromes, VPS13A gene mutation acanthocytes, basal ganglia atrophy, movement disorders

Authors

Institutions

Publication Details

Journal
Biomedical Sciences and Clinical Medicine
Published
2025-09-01
DOI
https://doi.org/10.12982/bscm.2025.36
Primary Topic
Neurological and metabolic disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A Rare Case of Chorea-Acanthocytosis in India: Clinical Presentation, Diagnosis, and Management

Anusha Challa, Shivaji Manthena, Ritesh Kumar, Shreya Nallapati
Biomedical Sciences and Clinical Medicine
Neurological and metabolic disorders
article

A Rare Case of Chorea-Acanthocytosis in India: Clinical Presentation, Diagnosis, and Management

Anusha Challa, Shivaji Manthena, Ritesh Kumar, Shreya Nallapati
article en

Abstract

Chorea-acanthocytosis (ChAc) is a rare autosomal recessive neurodegenerative disorder classified under Neuroacanthocytosis syndromes. It is characterized by progressive neurological decline, psychiatric symptoms, and the presence of irregularly shaped red blood cells (acanthocytes) on peripheral blood smears. ChAc remains underdiagnosed due to its rarity and variable presentation. This case report describes a 44-year-old male from India, born of a consanguineous marriage, who presented with self-mutilating lip-biting or lingual dystonia, generalized chorea, and a history of seizures. The patient exhibited psychiatric symptoms including depression and agitation in addition to neurological features such as hypophonic speech, slowed saccades, and hypotonia. Initial diagnoses of tardive dyskinesia and generalized tonic-clonic seizures were revised following referral to neurology. Peripheral blood smears revealed acanthocytosis, and whole-exome sequencing confirmed a homozygous mutation in the VPS13A gene, leading to the diagnosis of ChAc. MRI findings included bilateral caudate and lentiform nucleus atrophy, with mild cerebral atrophy. The patient was treated symptoms were managed with antiepileptics, dopamine receptor antagonists, anticholinergics and vitamin supplementation, and vitamin supplementation, resulting in significant improvement in mandibular and lingual symptoms. Dental guards were provided to prevent further oral injury. This case highlights the importance of considering ChAc in patients presenting with neuropsychiatric and movement disorder symptoms, especially in the context of consanguinity. Early recognition and multidisciplinary management are crucial to improving quality of life. By documenting this rare case, we aim to enhance clinical awareness and facilitate early diagnosis of ChAc in resource-limited settings KEYWORDS chorea-acanthocytosis (Chac), neuroacanthocytosis syndromes, VPS13A gene mutation acanthocytes, basal ganglia atrophy, movement disorders

Biomedical Sciences and Clinical MedicineVol. 64(4)
University of Hyderabad (IN), Krishna Institute of Medical Sciences (IN), Institute of Medical Sciences (IN)
Openalex Percentile: Top 67%
Neurological and metabolic disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.